[1]
Gado, T.H., Asal, S.A., Abdelraouf, F.H. and AbdelSamie, R. 2022. Evaluating Serum Neuregulin 4 as a Noninvasive Biomarker in Patients with Non-alcoholic Fatty Liver Disease. Open Access Macedonian Journal of Medical Sciences. 10, B (Apr. 2022), 1007–1013. DOI:https://doi.org/10.3889/oamjms.2022.9354.